Skip to main content

Mouse Monoclonal LYN antibody. Suitable for Flow Cyt, WB and reacts with Human, Rat, Recombinant full length protein - Human samples. Cited in 21 publications. Immunogen corresponding to Recombinant Fragment Protein within Human LYN aa 1-250.


Images

Western blot - Anti-Lyn antibody [LYN-01] (AB1890), expandable thumbnail
  • Western blot - Anti-Lyn antibody [LYN-01] (AB1890), expandable thumbnail
  • Flow Cytometry - Anti-Lyn antibody [LYN-01] (AB1890), expandable thumbnail
  • Western blot - Anti-Lyn antibody [LYN-01] (AB1890), expandable thumbnail

Publications

Key facts

Isotype
IgG1
Host species
Mouse
Storage buffer

pH: 7.4
Preservative: 0.097% Sodium azide
Constituents: PBS

Form
Liquid
Clonality
Monoclonal

Immunogen

  • Recombinant Fragment Protein within Human LYN aa 1-250. The exact immunogen used to generate this antibody is proprietary information. Database link P07948

Reactivity data

Select an application
Product promiseTestedExpectedPredictedNot recommended
Flow CytWB
Human
Tested
Tested
Rat
Expected
Tested
Recombinant full length protein - Human
Not recommended
Tested

Tested
Tested

Species
Human
Dilution info
1 µg for 106 Cells
Notes

ab170190 - Mouse monoclonal IgG1, is suitable for use as an isotype control with this antibody.

Expected
Expected

Species
Rat
Dilution info
Use at an assay dependent concentration.
Notes

-

Not recommended
Not recommended

Species
Recombinant full length protein - Human
Dilution info
-
Notes

-

Tested
Tested

Species
Recombinant full length protein - Human
Dilution info
1-2 µg/mL
Notes

-

Species
Rat
Dilution info
1-2 µg/mL
Notes

-

Species
Human
Dilution info
1-2 µg/mL
Notes

-

Associated Products

Select an associated product type

7 products for Alternative Product

Target data

Function

Non-receptor tyrosine-protein kinase that transmits signals from cell surface receptors and plays an important role in the regulation of innate and adaptive immune responses, hematopoiesis, responses to growth factors and cytokines, integrin signaling, but also responses to DNA damage and genotoxic agents. Functions primarily as negative regulator, but can also function as activator, depending on the context. Required for the initiation of the B-cell response, but also for its down-regulation and termination. Plays an important role in the regulation of B-cell differentiation, proliferation, survival and apoptosis, and is important for immune self-tolerance. Acts downstream of several immune receptors, including the B-cell receptor, CD79A, CD79B, CD5, CD19, CD22, FCER1, FCGR2, FCGR1A, TLR2 and TLR4. Plays a role in the inflammatory response to bacterial lipopolysaccharide. Mediates the responses to cytokines and growth factors in hematopoietic progenitors, platelets, erythrocytes, and in mature myeloid cells, such as dendritic cells, neutrophils and eosinophils. Acts downstream of EPOR, KIT, MPL, the chemokine receptor CXCR4, as well as the receptors for IL3, IL5 and CSF2. Plays an important role in integrin signaling. Regulates cell proliferation, survival, differentiation, migration, adhesion, degranulation, and cytokine release. Involved in the regulation of endothelial activation, neutrophil adhesion and transendothelial migration (PubMed:36932076). Down-regulates signaling pathways by phosphorylation of immunoreceptor tyrosine-based inhibitory motifs (ITIM), that then serve as binding sites for phosphatases, such as PTPN6/SHP-1, PTPN11/SHP-2 and INPP5D/SHIP-1, that modulate signaling by dephosphorylation of kinases and their substrates. Phosphorylates LIME1 in response to CD22 activation. Phosphorylates BTK, CBL, CD5, CD19, CD72, CD79A, CD79B, CSF2RB, DOK1, HCLS1, LILRB3/PIR-B, MS4A2/FCER1B, SYK and TEC. Promotes phosphorylation of SIRPA, PTPN6/SHP-1, PTPN11/SHP-2 and INPP5D/SHIP-1. Mediates phosphorylation of the BCR-ABL fusion protein. Required for rapid phosphorylation of FER in response to FCER1 activation. Mediates KIT phosphorylation. Acts as an effector of EPOR (erythropoietin receptor) in controlling KIT expression and may play a role in erythroid differentiation during the switch between proliferation and maturation. Depending on the context, activates or inhibits several signaling cascades. Regulates phosphatidylinositol 3-kinase activity and AKT1 activation. Regulates activation of the MAP kinase signaling cascade, including activation of MAP2K1/MEK1, MAPK1/ERK2, MAPK3/ERK1, MAPK8/JNK1 and MAPK9/JNK2. Mediates activation of STAT5A and/or STAT5B. Phosphorylates LPXN on 'Tyr-72'. Kinase activity facilitates TLR4-TLR6 heterodimerization and signal initiation. Phosphorylates SCIMP on 'Tyr-107'; this enhances binding of SCIMP to TLR4, promoting the phosphorylation of TLR4, and a selective cytokine response to lipopolysaccharide in macrophages (By similarity). Phosphorylates CLNK (By similarity). Phosphorylates BCAR1/CAS and NEDD9/HEF1 (PubMed:9020138).

Alternative names

Recommended products

Mouse Monoclonal LYN antibody. Suitable for Flow Cyt, WB and reacts with Human, Rat, Recombinant full length protein - Human samples. Cited in 21 publications. Immunogen corresponding to Recombinant Fragment Protein within Human LYN aa 1-250.

Key facts

Isotype
IgG1
Form
Liquid
Clonality
Monoclonal
Immunogen
  • Recombinant Fragment Protein within Human LYN aa 1-250. The exact immunogen used to generate this antibody is proprietary information. Database link P07948
Clone number
LYN-01
Purification technique
Affinity purification Protein A
Concentration
Loading...
Purification notes

Purified from hybridoma culture supernatant. Purity >95% by SDS-PAGE.

Storage

Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Notes


Lyn is a member of the src family of non-receptor protein tyrosine kinases that is predominantly expressed in haematopoietic tissues. Like all members of the src family, lyn is thought to participate in signal transduction from cell surface receptors that lack intrinsic tyrosine kinase activity. It is associated with a number of cell surface receptors including the B cell antigen receptor and immunoglobulin E receptor (FceRI).

Supplementary info

This supplementary information is collated from multiple sources and compiled automatically.
Activity summary

Lyn kinase also known as p56 or Lyn protein is a member of the Src family of protein tyrosine kinases. It possesses a molecular weight of approximately 56 kDa. Lyn is mainly expressed in hematopoietic cells such as B-lymphocytes mast cells and myeloid cells. It plays a critical role in the signaling pathways involving these cells. Lyn is located on the inner surface of the plasma membrane and requires lipid modification for membrane association. Additionally it is present in neuronal tissues and other non-immune cell types reflecting a broader role in cellular signal transduction.

Biological function summary

As a regulator in signal transduction Lyn kinase is involved in the formation of protein complexes that modulate cell activation and proliferation. It participates in the phosphorylation of downstream substrates which leads to the initiation of various cellular responses. Lyn modulates pathways involving inflammation and immune responses impacting the development and function of immune cells. It is important for balancing activation and inhibition signals in the immune system ensuring a controlled immune response.

Pathways

Lyn kinase interacts with the B-cell receptor (BCR) signaling pathway and the Fc epsilon RI signaling pathway in mast cells. It associates with other Src family kinases like Fyn and Lck to regulate BCR signaling which influences B-cell development and differentiation. Lyn also acts upstream of pathways that control the release of inflammatory mediators. Through its role in these pathways Lyn indirectly impacts downstream processes and affects cellular communication and immune system homeostasis.

Associated diseases and disorders

Lyn dysfunction has implications for conditions like chronic myeloid leukemia and systemic lupus erythematosus. Abnormal Lyn activity alters signal transduction leading to unregulated cell proliferation and immune dysregulation. In chronic myeloid leukemia Lyn interacts with the BCR/ABL fusion protein contributing to the malignant transformation of hematopoietic cells. In systemic lupus erythematosus Lyn regulates signaling pathways that prevent autoimmunity; imbalances can lead to an excessive immune response. These connections highlight Lyn's importance in both cell regulation and its involvement in pathological states.

Product promise

We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.

In the unlikely event of one of our products not working as expected, you are covered by our product promise.

Full details and terms and conditions can be found here:
Terms & Conditions.

4 product images

  • Western blot - Anti-Lyn antibody [LYN-01] (ab1890), expandable thumbnail

    Western blot - Anti-Lyn antibody [LYN-01] (ab1890)

    Non reducing conditions with 60 minutes exposure time in a 12% gel

    All lanes: Western blot - Anti-Lyn antibody [LYN-01] (ab1890) at 1 µg/mL

    Lane 1: Negative control

    Lane 2: Rat basophilic leukemia cell line

    Lane 3: JURKAT human peripheral blood T cell leukemia cell line

    Lane 4: A-431 human epidermoid carcinoma cell line

    Lane 5: U-937 human histiocytic lymphoma cell line

    Predicted band size: 59 kDa

  • Western blot - Anti-Lyn antibody [LYN-01] (ab1890), expandable thumbnail

    Western blot - Anti-Lyn antibody [LYN-01] (ab1890)

    All lanes: Western blot - Anti-Lyn antibody [LYN-01] (ab1890) at 1/1000 dilution

    All lanes: Recombinant human Lyn protein (ab60306) at 0.01 µg

    Secondary

    All lanes: Western blot - Goat Anti-Mouse IgG H&L (HRP) preadsorbed (Goat Anti-Mouse IgG H&L (HRP) preadsorbed ab97040) at 1/3000 dilution

    Developed using the ECL technique.

    Performed under reducing conditions.

    Predicted band size: 59 kDa

    Exposure time: 4min

  • Flow Cytometry - Anti-Lyn antibody [LYN-01] (ab1890), expandable thumbnail

    Flow Cytometry - Anti-Lyn antibody [LYN-01] (ab1890)

    Overlay histogram showing Ramos (Human Burkitt's lymphoma cell line) cells stained with ab1890 (red line). The cells were fixed with 80% methanol (5 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab1890, 1μg/1x106 cells) for 30 min at 22°C. The secondary antibody used was DyLight® 488 goat anti-mouse IgG (H+L) (Goat Anti-Mouse IgG H&L (DyLight® 488) preadsorbed ab96879) at 1/500 dilution for 30 min at 22°C. Isotype control antibody (black line) was mouse IgG1 [ICIGG1] (Mouse IgG1, Kappa Monoclonal [B11/6] - Isotype Control ab91353, 2μg/1x106 cells) used under the same conditions. Acquisition of >5,000 events was performed. This antibody gave a positive signal in Ramos cells fixed with 4% paraformaldehyde (10 min)/permeabilized with 0.1% PBS-Tween for 20 min used under the same conditions.

  • Western blot - Anti-Lyn antibody [LYN-01] (ab1890), expandable thumbnail
    Image courtesy of an anonymous customer review.

    Western blot - Anti-Lyn antibody [LYN-01] (ab1890)

    All lanes: Western blot - Anti-Lyn antibody [LYN-01] (ab1890) at 1/1000 dilution

    All lanes: HEK-293 (Human epithelial cell line from embryonic kidney) whole cell lysate at 50 µg

    Secondary

    All lanes: HRP-conjugated anti-mouse at 1/10000 dilution

    Predicted band size: 59 kDa

    Observed band size: 56 kDa

Downloads

Product protocols

For this product, it's our understanding that no specific protocols are required. You can:

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com